Skip to main content

Alcon Value Stock - Dividend - Research Selection

Alcon

ISIN: CH0432492467, WKN: A2PDXE

Market price date: 20.07.2021
Market price: 63,38 CHF




Alcon Fundamental data and company key figures of the share

Annual reports in CHF
Key figures 23-09-2020
Cash flow
Net operating cash flow 823.000.000
Capital Expenditures -479.000.000
Free cash flow 244.000.000
Balance sheet
Total Equity 18.822.000.000
Liabilities & Shareholders equity 27.600.000.000
Income statement
Net income -531.000.000
Eps (diluted) -1,085
Diluted shares outstanding 489.219.000
Net sales/revenue 6.833.000.000

Fundamental ratios calculated on: 20-07-2021

Ratios
Key figures 20-07-2021
Cash flow
P/C 33,67
   
P/FC 126,94
Balance sheet
ROI-2,37
ROE69,80
Income statement
P/E-47,30
Div. Yield0,00%
P/B1,61
P/S4,13


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
SymbolALC.SW
Market Capitalization31.728.955.392,00 USD
Country
IndicesSMI,SPI
Sectors
Raw Data SourceIFRS in Millionen CHF
Stock Split
Internetwww.alcon.com


Description of the company

Alcon, Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients. It operates through two segments, Surgical and Vision Care. The Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures, such as cataracts, vitreoretinal, refractive laser, and glaucoma surgery. Its cataract products include centurion vision system, LenSx femtosecond laser, LuxOR ophthalmic microscope, verion imaged guided system, and ORA System for intra-operative measurements and guidance; vitreoretinal products comprising constellation vision system, grieshaber DSP and MIVS instrumentation, ultravit high speed vitrectomy probes, purepoint laser, and NGENUITY 3D visualization system; refractive surgery products, including WaveLight lasers and diagnostics used for LASIK; and glaucoma product, such as EX-PRESS glaucoma filtration device, as well as AcrySof IQ IOLs products include monofocal IOLs and advanced technology IOLs under PanOptix and ReSTOR brands for the correction of presbyopia and astigmatism at the time of cataract surgery. The Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, including devices and over-the-counter products for dry eye, over-the-counter products for contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers under the TOTAL, PRECISION, Dailies, Air Optix, Systane, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux brands. The company was formerly known as Alcon Universal S.A. and changed the name to Alcon, Inc. in December 2001. Alcon, Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.alcon.com